Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The presentation highlighted progress on a first-in-class menin inhibitor for diabetes, showing promising phase II results in both Type 1 and Type 2 diabetes, and a next-generation GLP-1 agent with improved tolerability. Key clinical readouts and potential licensing activities are expected within t…
The presentation highlighted a focused pipeline with a first-in-class menin inhibitor for diabetes and a next-generation GLP-1 agonist, both showing promising phase II results in efficacy and safety. Key readouts and regulatory milestones are expected by the end of next year.Based on Biomea Fusion…